Back

24-month results and technical approach of catheter-based renal denervation in patients with resistant hypertension

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Recent advances in diagnosis/treatment of hypertension Device Treatment and Intervention ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Associate Professor Daniil Maximkin

Peoples Friendship University of Russia (PFUR), Moscow (Russian Federation)

3 More presentations in this session

Presentation thumbnail
Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage
Doctor P. Kolkhof (Wuppertal, DE)
Abstract Slides Video
Presentation thumbnail
Potential therapeutic efficacy via avB3-integrin dependent interaction of developmental endothelial locus-1 (Del-1) after established angiotensin-II dependent hypertension
Mr M. Amponsah-Offeh (Mannheim, DE)
Abstract Slides Video
Presentation thumbnail
Protective effects of renal denervation based on MRI assessment of the brain in patients with resistant hypertension
Doctor A. Sukhareva (Tomsk, RU)
Abstract Slides Video

Access the full session

Session thumbnail
Recent advances in diagnosis/treatment of hypertension

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Blood pressure should be lowered as low as possible - discussion
thumbnail
Congress Presentation
Renal denervation is one of the pillars of management of resistant hypertension: pro
thumbnail
Congress Presentation
Should we intervene early in patients with asymptomatic aortic stenosis?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources